MétaCan
Menu
Back to cohort
Record W2055113707 · doi:10.1016/j.jalz.2012.05.1108

P2‐398: Targeting alzheimeric pathologies using small‐molecule therapies: A multi‐targeted approach

2012· article· en· W2055113707 on OpenAlexaff
Tarek Mohamed, Jacky T. Yeung, Praveen P. N. Rao

Bibliographic record

VenueAlzheimer s & Dementia · 2012
Typearticle
Languageen
FieldMedicine
TopicCholinesterase and Neurodegenerative Diseases
Canadian institutionsUniversity of Waterloo
Fundersnot available
KeywordsPharmacophoreDrug discoveryDocking (animal)Small moleculePharmacologyChemistryRational designDrug developmentCholinesteraseComputational biologyDrugDrug designMedicineBiochemistryBiologyNanotechnologyMaterials science

Abstract

fetched live from OpenAlex

The complex pathophysiology of Alzheimer's disease (AD) mandates the phase-out of the ‘one drug, one target’ method in favor of a multi-targeted approach for the development of novel AD pharmacotherapies. Multifunctional treatments that target various Alzheimeric pathologies are likely to inflict a disease-modifying effect (DME) that can halt and/or reverse disease progression. Our research encompasses the design, development and biological evaluation of novel heterocyclic compounds with an Alzheimeric multifunctional profile. Emphasis is on targeting cholinergic dysfunction (via cholinesterase inhibition), amyloid toxicities (via Aβ-aggregation inhibition, radical scavenging) and tau pathology (via T-aggregation inhibition). Methodology utilizes advanced computational, chemical and biological tools to generate a biological profile for compounds within a chemical library. In vitro, in situ and in vivo assessments are conducted and combined with molecular docking studies to acquire structure-activity relationship data (SAR) that can identify novel pharmacophores for a multi-targeted therapeutic strategy. Our recent efforts with developing a 2,4-disubstituted pyrimidine ring (DPR) template yielded promising results in achieving multifunctional activity against the cholinesterases, Aβ aggregation and β-secretase. In our quest to improve cholinesterase potency and add to the biological profile, we are investigating the potential of heteroatom-based, bicyclic rings as a substitute for the 2,4 DPR template. These novel bicyclic-based compounds will incorporate features necessary to attain dual cholinesterase inhibition, multi-mode Aβ aggregation inhibition and antioxidant capabilities. The design also focuses on establishing a good pharmacological profile with favorable blood-brain-barrier passage. Preliminary docking studies demonstrated the ability of these bicyclic compounds to closely interact with the catalytic site of both cholinesterases as well as extend toward the peripheral site of AChE. In addition, the heterocyclic nature of the template ring allows it to interact with various key aggregation residues of the Aβ and tau peptides. The size and chemical nature of the substituents attached to the bicyclic template govern the compounds biological capabilities.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.012

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0010.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0030.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.101
GPT teacher head0.319
Teacher spread0.218 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2012
Admission routes1
Has abstractyes

Explore more

Same venueAlzheimer s & DementiaSame topicCholinesterase and Neurodegenerative DiseasesFrench-language works237,207